Skip to main content
. 2022 Jun 3;9:831541. doi: 10.3389/fmed.2022.831541

Table 3.

Adverse events during sacubitril-valsartan treatment.

Events McMurray et al.*(N = 4,203) (%) Tang et al.**(N = 21) (%) Current study (N = 47) (%)
Hypotension 17.6 0 0
Hyperkalaemia 11.6 0 0
Cough 8.8 0 0
Renal impairment 10.1 0 0
Angioedema 0.5 0 0
*

McMurray et al. (6).

**

Fu et al. (8).